BioScience Health Innovations (BHIC) Liabilities and Shareholders Equity (2019 - 2026)

BioScience Health Innovations (BHIC) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $2.3 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $2.3 million, up 67.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.2 million (up 181.62% YoY), and the FY2025 annual result was $1.7 million, up 95.38% from the prior year.
• Liabilities and Shareholders Equity climbed to $2.3 million in Q1 2026 per BHIC's latest filing, from $1.7 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.3 million in Q1 2026 and troughed at $16253.0 in Q3 2022.
• A 5-year average of $684338.2 and a median of $154798.0 in 2024 frame the typical range for Liabilities and Shareholders Equity.
• On a YoY basis, Liabilities and Shareholders Equity climbed as much as 6439.04% in 2022 and fell as far as 70.52% in 2022.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $28343.0 in 2022, then surged by 229.49% to $93388.0 in 2023, then surged by 835.65% to $873788.0 in 2024, then soared by 95.38% to $1.7 million in 2025, then jumped by 36.5% to $2.3 million in 2026.
• Business Quant data shows BHIC's Liabilities and Shareholders Equity at $2.3 million in Q1 2026, $1.7 million in Q4 2025, and $2.1 million in Q3 2025.